Thyroid C-mobile Tumors: In rodent experiments, semaglutide continues to be revealed to lead to thyroid C-mobile tumors. It's unidentified whether or not this risk relates to humans, but semaglutide is contraindicated in patients with a private or family record of medullary thyroid carcinoma (MTC) or people with Many Endocrine Neoplasia syndrome ki